Recent Advances in Biotherapies - Genetic Technology TOE

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts the new life sciences trends across biotherapies. Different cutting-edge technologies such as nanotechnologies and next-generation antibodies are profiled. The corresponding patent scenario related to viral immunotherapies is depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cell

Table of Contents

Recent Advances in Biotherapies - Genetic Technology TOETechnology ProfilesSmart Nanoparticles for Cancer TherapyNovel Therapeutic ClassNext Generation of Oncolytic Viral TherapiesCollaborative Development of Monoclonal Antibodies for Immuno-oncologyPatent AnalysisGlobal Patent Analysis for Viral ImmunotherapiesGlobal Patent Analysis for Viral ImmunotherapiesAppendixPatent ScenarioPatent ScenarioIndustry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.